| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 06/07/2006 | EP1666491A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2006 | EP1666481A2 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo[2,3]pyrimidine derivatives as protein kinases inhibitors |
| 06/07/2006 | EP1666480A1 Aryl or Heteroaryl Fused Imidazole Compounds as intermediates for Anti-Inflammatory And Analgesic Agents. |
| 06/07/2006 | EP1666473A1 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 06/07/2006 | EP1666065A1 Therapeutic agent for autoimmune disease |
| 06/07/2006 | EP1666062A2 Therapeutic applications for the anti-T-BAM (CD40-L) monoclonal antibody 5c8 |
| 06/07/2006 | EP1666045A1 Sphingomyelin containing preparation for the enhancement of tumor therapy and for the treatment of rheumatoid arthritis |
| 06/07/2006 | EP1666033A1 Prevention and treatment of androgen-deprivation induced osteoporosis |
| 06/07/2006 | EP1666028A1 Dry powder compositions having improved dispersivity |
| 06/07/2006 | EP1664315A1 Aav vectors for in vivo gene therapy of rheumatoid arthritis |
| 06/07/2006 | EP1664047A1 Substituted indolizine 1,2,3,6,7,8 derivatives, fgfs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives |
| 06/07/2006 | EP1664013A1 Calcilytic compounds |
| 06/07/2006 | EP1663958A2 Haloalkyl containing compounds as cysteine protease inhibitors |
| 06/07/2006 | EP1663300A1 Inhibitors of pace4 for the treatment of arthritis |
| 06/07/2006 | EP1663294A1 Treatment of fibrotic disease |
| 06/07/2006 | EP1663288A2 Methods of using wisp antagonists |
| 06/07/2006 | EP1663233A1 Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis |
| 06/07/2006 | EP1663224A1 A pharmaceutical composition comprising a p2x7 receptor antagonist and a nonsteroidal anti inflammatory drug |
| 06/07/2006 | EP1663185A1 Prevention and treatment of inflammation-induced and/or immune-mediated bone loss |
| 06/07/2006 | EP1421075B1 Piperidine derivatives useful as ccr5 antagonists for the treatment of hiv |
| 06/07/2006 | EP1406878B1 4-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1, 2, 4) triazin-5-one derivatives having a pde-iv inhibiting and tnf-antagonistic effect for the treatment of cardiac diseases and allergies |
| 06/07/2006 | EP1378510B1 Triazaspiro (5.5) undecane derivatives and drugs containing the same as the active ingredient |
| 06/07/2006 | EP1364023B1 Gene highly expressed in cartilage tissues |
| 06/07/2006 | EP1334367B1 A method of determining the initial dose of vitamin d compounds |
| 06/07/2006 | EP1265630B1 Use of insulin for the treatment of cartilagenous disorders |
| 06/07/2006 | EP1002081B1 Delayed progression to aids by a missense allele of the ccr2 gene |
| 06/07/2006 | CN1784415A Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 06/07/2006 | CN1784405A Microcrystal |
| 06/07/2006 | CN1784403A Azaindole compounds as kinase inhibitors |
| 06/07/2006 | CN1784402A Imidazo and thiazolopyridines as JAK3 kinase inhibitors |
| 06/07/2006 | CN1784380A Novel bioisosteres of actinonin |
| 06/07/2006 | CN1781947A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781946A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781945A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781890A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 06/07/2006 | CN1781543A Ant oil liniment and its preparing method |
| 06/07/2006 | CN1781541A Chinese medicine preparation for treating gout |
| 06/07/2006 | CN1781540A Medicinal pad for treating rheumatoid disease |
| 06/07/2006 | CN1781535A Medicine for treating osteoporosis and its preparing method and use |
| 06/07/2006 | CN1781532A Plaster for removing obstruction in channels and relieving pain |
| 06/07/2006 | CN1781524A Medicinal soft capsule for treating osteoproliferation and its preparing method |
| 06/07/2006 | CN1781511A Application of plant extract for preparing medicine to cure bone absorption increment diseases and composition thereof |
| 06/07/2006 | CN1781510A Use of sea-buckthorn fruit oil and/or fruit slag oil in preparing medicine for treating osteoporosis |
| 06/07/2006 | CN1781506A American ginseng and royal jelly soft capsule |
| 06/07/2006 | CN1781500A Use of red yeast in preparing anti-inflammatory medicine |
| 06/07/2006 | CN1781497A Plant female sex hormone and probiotics for keeping woman health |
| 06/07/2006 | CN1781489A Wet granulation formulation for bisphosphonic acids |
| 06/07/2006 | CN1258551C Preparing method of degradable polymer |
| 06/07/2006 | CN1258380C Utilization of ADAMTS-1 protein and method of screening aggrecanase activity regulator |
| 06/07/2006 | CN1258376C Plaster for treating hyperosteogeny |
| 06/07/2006 | CN1258375C Method for preparing medicine for treating rheumatoid arthritis |
| 06/07/2006 | CN1258373C Medicine for treating lumbosacral pain and its preparing method |
| 06/07/2006 | CN1258371C Compositions comprising organic extracts of Geum Japonicum thunb var. and the use thereof |
| 06/07/2006 | CN1258359C Pharmaceutical compositions |
| 06/06/2006 | US7056944 Pyrazole compositions useful as inhibitors of erk |
| 06/06/2006 | US7056937 Sulfonylquinoxalone derivatives as bradykinin antagonists |
| 06/06/2006 | US7056933 For therapy of arthritis, fever, common cold, dysmenorrhea, menstrual cramps, inflammatory bowel disease, Crohn's disease, emphysema, acute respiratory distress syndrome, asthma, bronchitis, chronic obstructive pulmonary disease, etc. |
| 06/06/2006 | US7056931 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods |
| 06/06/2006 | US7056915 Compounds useful as reversible inhibitors of cysteine proteases |
| 06/06/2006 | US7056914 Benzoxazinone-derived compounds, their preparation and use as medicaments |
| 06/06/2006 | US7056909 5,5-Difluoro-3(S)-(pyrimidin-5-yl)-9-(5,6,7,8-tetrahydro-(1, 8)-naphthyridin-2-yl)-nonanoic acid; inhibition of bone resorption, restenosis, angiogenesis, retinopathy, macular degeneration, arthritis, metastatic tumor growth, etc. |
| 06/06/2006 | US7056905 Antiinflammatory agents; immunosuppressants |
| 06/06/2006 | US7056904 Therapy for bone disorders; osteoporosis; vitamin deficiency |
| 06/06/2006 | US7056903 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists |
| 06/06/2006 | US7056898 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
| 06/06/2006 | US7056895 1-(3,4-dihydroxy-5-methylol-tetrahydrofur-2-yl),3-amidino-1H-1,2,4- triazoles; infections, infestations, autoimmune diseases; anticarcinogenic and -tumor agents; HIV, hepatitis C, human papilloma virus and giant cell arteritis |
| 06/06/2006 | US7056711 Attenuation of fibroblast proliferation |
| 06/06/2006 | US7056655 Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism |
| 06/06/2006 | US7056275 Radiotherapy |
| 06/06/2006 | CA2327723C Bicyclic hydroxamic acid derivatives |
| 06/06/2006 | CA2242577C Skin-adhering pharmaceutical preparation, in particular transdermal therapeutic system for the release of 17-.beta.-estradiol to the human organism |
| 06/06/2006 | CA2213810C Benzo¬b|thiophene compounds, intermediates, processes, compositions and methods |
| 06/06/2006 | CA2136903C Acetic acid derivatives |
| 06/01/2006 | WO2006057507A1 An oral preparation having improved bioavailability |
| 06/01/2006 | WO2006057460A1 Nitrogen-containing fused ring compound and use thereof |
| 06/01/2006 | WO2006057346A1 Ameliorant for renal insufficiency |
| 06/01/2006 | WO2006057270A1 Nitrogeneous tricyclic compound |
| 06/01/2006 | WO2006057217A1 Dfrp proteins regulating drg proteins and utilization of the same |
| 06/01/2006 | WO2006057011A2 Use of chitosan for stimulating bone healing and bone formation |
| 06/01/2006 | WO2006018185A8 Dihydropteridinones for the treatment of cancer diseases |
| 06/01/2006 | WO2006014706A3 Methotrexate derivatives useful for treating cancer and arthritis |
| 06/01/2006 | WO2003025542A3 Immune response associated proteins |
| 06/01/2006 | US20060117414 Fad4, Fad5, Fad5-2, and Fad6, novel fatty acid desaturase family members and uses thereof |
| 06/01/2006 | US20060116518 Novel phenanthridines |
| 06/01/2006 | US20060116516 2-[[4-[[[4-(Aminosulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-4-methyl-5-thiazolecarboxylic acid, ethyl ester; 4-Methyl-2-[[4-[[[4-(methylsulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-5-thiazolecarboxylic acid, ethyl ester; Antiinflammatory agents; rheumatic diseases |
| 06/01/2006 | US20060116510 Isoflavone concentrates, as well as methods for their production |
| 06/01/2006 | US20060116388 CXCR3 antagonists |
| 06/01/2006 | US20060116364 Such as (R)-6-{2-{ethyl[4-(2-ethylaminoethyl)benzyl]amino }-4-methoxyphenyl }-5,6,7,8-tetrahydronaphthalen-2-ol; osteoporosis; breast cancer |
| 06/01/2006 | US20060116318 Preptin methods of use |
| 06/01/2006 | US20060115501 Homogeneously Formulating microdosed active principles |
| 06/01/2006 | US20060115470 Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders |
| 06/01/2006 | US20060115463 Composition of fibroblast or chondrocyte cells transfected or transduced with a gene encoding transforming growth factor beta 1 (TGF- beta 1) or bone morphogenetic protein 2 (BMP-2), and chondrocyte cells that have not been transfected with the gene; generating hyaline cartilage at a target site |
| 06/01/2006 | US20060115376 Irradiation in presence of stabilizer; preventing degradation |
| 06/01/2006 | CA2579962A1 Glycine as a diet supplement for the treatment of health problems that result from underlying metabolic disorders |
| 05/31/2006 | EP1661580A1 Remedy for cartilage-related diseases |
| 05/31/2006 | EP1661564A1 Heterocyclic compounds and their pharmaceutical use |
| 05/31/2006 | EP1660475A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 05/31/2006 | EP1660461A1 Novel condensed n-pyrazinyl-sulphonamides and their use in the treatment of chemokine mediated diseases |
| 05/31/2006 | EP1660184A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 05/31/2006 | EP1660108A1 Composition comprising notoginseng radix extract for preventing and treating arthritis as an effective ingredient |